0001925468-22-000001.txt : 20220505 0001925468-22-000001.hdr.sgml : 20220505 20220505092659 ACCESSION NUMBER: 0001925468-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20220505 DATE AS OF CHANGE: 20220505 EFFECTIVENESS DATE: 20220505 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QuantBio Innovations Fund LP CENTRAL INDEX KEY: 0001925468 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-444527 FILM NUMBER: 22894521 BUSINESS ADDRESS: STREET 1: C/O OBERLAND CAPITAL MANAGEMENT LLC STREET 2: 1700 BROADWAY, 37TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 212-257-5850 MAIL ADDRESS: STREET 1: C/O OBERLAND CAPITAL MANAGEMENT LLC STREET 2: 1700 BROADWAY, 37TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 D 1 primary_doc.xml X0708 D LIVE 0001925468 QuantBio Innovations Fund LP C/O OBERLAND CAPITAL MANAGEMENT LLC 1700 BROADWAY, 37TH FLOOR NEW YORK NY NEW YORK 10019 212-257-5850 DELAWARE None None Limited Partnership true 2021 JEAN-PIERRE NAEGELI C/O OBERLAND CAPITAL MANAGEMENT LLC 1700 BROADWAY, 37TH FLOOR NEW YORK NY NEW YORK 10019 Executive Officer ANDREW RUBINSTEIN C/O OBERLAND CAPITAL MANAGEMENT LLC 1700 BROADWAY, 37TH FLOOR NEW YORK NY NEW YORK 10019 Executive Officer Pooled Investment Fund Private Equity Fund false Decline to Disclose 06b 3C 3C.7 false true true true false 0 Indefinite 0 Indefinite false 0 0 0 0 false QuantBio Innovations Fund LP DAVID DUBINSKY DAVID DUBINSKY MANAGING MEMBER OF THE GENERAL PARTNER 2022-05-04